Acoustic neuromodulation for recovery and readiness

Acoustic neuromodulation for recovery and readiness

Proprietary technology for nervous system support.

Proprietary technology for nervous system support.

Sonocea® is a neuroscience technology company developing acoustic interventions designed to support autonomic nervous system regulation.

Powered by Sonic Augmentation Technology™ (SAT™), the Sonocea platform uses patent-pending signal-generation architecture and is designed for professional deployment.

Published Human Research

88.5%

(100/113) reported improved emotional and physical state after a 15 minute session BSI

Published Human Research

88.5%

(100/113) reported improved emotional and physical state after a 15 minute session BSI

Biological Measurement

72.7%

(24/33) showed biological signal increase in salivary oxytocin after a 15 minute session

Biological Measurement

72.7%

(24/33) showed biological signal increase in salivary oxytocin after a 15 minute session

US federal government funded research

70.3%

(46/58) reported improved emotional and physical state after four weeks of repeated use BSI

US federal government funded research

70.3%

(46/58) reported improved emotional and physical state after four weeks of repeated use BSI

Why it matters

Under sustained pressure, regulation matters

High-pressure organizations depend on people being able to recover and return to readiness.

Yet many approaches to regulation and recovery require dedicated time, active participation, specialist provision, or individual behavior change – making consistent deployment difficult.

Sonocea is designed to make nervous system support practical within demanding environments and at organizational scale.

Settle

Support the transition out of high-arousal states.

Recover

Create space for decompression between periods of demand.

Prepare

Support readiness for what comes next.

Technology

Technology

What makes Sonocea different

Our technology is in the signal.

Sonocea SAT uses patent-pending signal-generation architecture to create structured acoustic interventions designed to support autonomic nervous system regulation.

Unlike conventional meditation, music, or wellness content, Sonocea is built on proprietary acoustic technology and evaluated through human research and biological measurement.

Proprietary

Proprietary signal architecture generates the structured acoustic input.

Proprietary

Proprietary signal architecture generates the structured acoustic input.

Measurable

Clinically studied. Biologically measured.]

Measurable

Clinically studied. Biologically measured.]

Scalable

Digital delivery through existing audio devices and partner platforms.

Scalable

Digital delivery through existing audio devices and partner platforms.

Non-invasive

No drugs. No implants. No specialist hardware.

Non-invasive

No drugs. No implants. No specialist hardware.

Low-friction

No training or active participation required.

Low-friction

No training or active participation required.

The Sonocea platform

Built on five decades of autonomic neuroscience

Sophisticated neuroscience. Simple delivery.

SAT generates structured acoustic signals designed to support autonomic nervous system regulation through the auditory pathway.

1

Structured acoustic signal

Precision-engineered SAS generates structured acoustic signals.

1

Structured acoustic signal

Precision-engineered SAS generates structured acoustic signals.

1

Structured acoustic signal

Precision-engineered SAS generates structured acoustic signals.

2

Auditory processing

The signal is processed through the auditory pathway.

2

Auditory processing

The signal is processed through the auditory pathway.

3

Nervous system regulation

Supports autonomic nervous system regulation.

3

Nervous system regulation

Supports autonomic nervous system regulation.

4

Measurable response

Associated with measurable changes in brain-stem state and biology.

4

Measurable response

Associated with measurable changes in brain-stem state and biology.

1

Measurable response

Associated with measurable changes in brain-stem state and biology.

Engineered

SAT generates structured, bespoke acoustic signals.

Engineered

SAT generates structured, bespoke acoustic signals.

Delivered

Played through ordinary headphones, speakers, apps, or embedded in partner platforms.

Delivered

Played through ordinary headphones, speakers, apps, or embedded in partner platforms.

Measured

Human studies show improvements in biobehavioral state alongside measured changes in salivary oxytocin.

Measured

Human studies show improvements in biobehavioral state alongside measured changes in salivary oxytocin.

Science

& Evidence

Science

& Evidence

Science & evidence

Human studies show both rapid response and improvement with repeated use

Human research has measured both rapid response after a single 15-minute SAT exposure and change following repeated use over four weeks.

Evidence includes peer-reviewed research and a completed US federal government-supported randomized study, using behavioral measures alongside biological measurement.

15 MINUTES · PEER-REVIEWED · PUBLISHED 2026

A measurable shift after a single SAT exposure

University of Florida College of Medicine · n=113

Following one 15-minute SAT exposure:

88.5%

(100/113)

reported improved emotional and physical state

BSI

Statistically significant within-participant changes

Improvements were observed across measures of calm/regulatory state, high-arousal/distress measures and total biobehavioral state.

p = .001

72.7%

(24/33)

reported improved emotional and physical state

BSI

p = .001

What this means

After just 15 minutes, participants reported improvements in measured aspects of biobehavioral state, with reduced high-arousal/distress measures and increased calm/regulatory measures. The salivary oxytocin findings provide evidence of a measurable biological response alongside those reported changes.

Why this matters

For people under sustained pressure, the ability to shift state quickly could make nervous system regulation more practical within the realities of a demanding day. For organizations, a 15-minute, passive intervention creates the potential for support that can be integrated into existing routines without specialist equipment or extensive training.

Dale et al., Frontiers in Psychiatry (2026).   

Read the peer-reviewed study

15 MINUTES · PEER-REVIEWED · PUBLISHED 2026

A measurable shift after a single SAT exposure

University of Florida College of Medicine · n=113

Following one 15-minute SAT exposure:

88.5%

(100/113)

reported improved emotional and physical state

BSI

Statistically significant within-participant changes

Improvements were observed across measures of calm/regulatory state, high-arousal/distress measures and total biobehavioral state.

p = .001

72.7%

(24/33)

reported improved emotional and physical state

BSI

p = .001

What this means

After just 15 minutes, participants reported improvements in measured aspects of biobehavioral state, with reduced high-arousal/distress measures and increased calm/regulatory measures. The salivary oxytocin findings provide evidence of a measurable biological response alongside those reported changes.

Why this matters

For people under sustained pressure, the ability to shift state quickly could make nervous system regulation more practical within the realities of a demanding day. For organizations, a 15-minute, passive intervention creates the potential for support that can be integrated into existing routines without specialist equipment or extensive training.

Dale et al., Frontiers in Psychiatry (2026).   

Read the peer-reviewed study

US Federal Government

FOUR WEEKS | RANDOMIZED STUDY | MANUSCRIPT ACCEPTED IN NEUROMODULATION

Improvement following four weeks of repeated use

US federal government-supported Long COVID study · n=250

Following four weeks of repeated intervention:

79.3%

(46/58)

reported improved emotional and physical state

BSI

Significant improvements

in fatigue, cognition, sleep and everyday functioning

SAT produced large, statistically significant improvements in fatigue and circulation-related symptoms, alongside significant benefits in cognition, breathing, sleep, mental health, and daily functioning.

What this means

The study extends Sonocea research from a single 15-minute exposure to repeated use over four weeks, allowing SAT to be evaluated as part of an ongoing approach to nervous system regulation and recovery.

Why this matters

For organizations considering Sonocea as part of ongoing workforce support, repeated-use research is important in understanding how the technology could be integrated into regular recovery routines rather than used only as a one-off intervention.

Study completed · Manuscript peer reviewed and pending publication

View the study

US Federal Government

FOUR WEEKS | RANDOMIZED STUDY | MANUSCRIPT ACCEPTED IN NEUROMODULATION

Improvement following four weeks of repeated use

US federal government-supported Long COVID study · n=250

Following four weeks of repeated intervention:

79.3%

(46/58)

reported improved emotional and physical state

BSI

Significant improvements

in fatigue, cognition, sleep and everyday functioning

SAT produced large, statistically significant improvements in fatigue and circulation-related symptoms, alongside significant benefits in cognition, breathing, sleep, mental health, and daily functioning.

What this means

The study extends Sonocea research from a single 15-minute exposure to repeated use over four weeks, allowing SAT to be evaluated as part of an ongoing approach to nervous system regulation and recovery.

Why this matters

For organizations considering Sonocea as part of ongoing workforce support, repeated-use research is important in understanding how the technology could be integrated into regular recovery routines rather than used only as a one-off intervention.

Study completed · Manuscript peer reviewed and pending publication

View the study

Research program

A growing program of human research

The Sonocea research program includes academic and government-supported human studies, from published research to further clinical evaluation.

PUBLISHED · 2026

Single-session feasibility study evaluating response following one 15-minute SAT exposure.

Peer-reviewed · Frontiers in Psychiatry

PUBLISHED · 2026

Single-session feasibility study evaluating response following one 15-minute SAT exposure.

Peer-reviewed · Frontiers in Psychiatry

US FEDERAL GOVERNMENT

COMPLETED

Four-arm randomized Long COVID study evaluating repeated use over four weeks.

Peer reviewed and pending publication | Neuromodulation

COMPLETED

Four-arm randomized Long COVID study evaluating repeated use over four weeks.

Peer reviewed and pending publication | Neuromodulation

PUBLISHED · 2026

Further human research approved to proceed.

PUBLISHED · 2026

Further human research approved to proceed.

AWAITING IRB APPROVAL

Further research in development.

AWAITING IRB APPROVAL

Further research in development.

Applications

Applications

Applications

Built first for people under pressure

Sonocea is initially focused on people working in demanding environments where sustained stress, high arousal and limited opportunities to recover can affect how they feel and function.

Frontline healthcare

A practical way to support nervous system regulation around demanding shifts - helping people decompress, recover and prepare for what comes next.

Frontline healthcare

A practical way to support nervous system regulation around demanding shifts - helping people decompress, recover and prepare for what comes next.

Defense & emergency response

Supporting people working in high-pressure environments where the ability to regulate, recover and return to readiness matters.

Defense & emergency response

Supporting people working in high-pressure environments where the ability to regulate, recover and return to readiness matters.

Designed for demanding environments

A 15-minute, passive intervention delivered through ordinary audio devices, with minimal training and no specialist hardware.

Designed for demanding environments

A 15-minute, passive intervention delivered through ordinary audio devices, with minimal training and no specialist hardware.

Applications: elite sport

The same need exists in elite sport

The same need exists in elite sport

Regulation matters in performance

Elite athletes move quickly between very different physiological and psychological demands - from high arousal and intense competition to recovery, rest and preparation for the next performance.

Supporting the ability to shift state could help athletes transition more effectively between periods of demand and rest - creating the conditions for recovery and readiness when they matter most.

Built to fit existing routines

Passive listening sessions can be incorporated around training, competition, recovery and travel using ordinary audio devices.

Early evidence in elite sport

Evaluated in a professional soccer environment

87.5%

(21 out of 24 participants)

In an uncontrolled feasibility pilot, 87.5% (21 out of 24 participants) improved, showing a reduction in the high-arousal measure following a Sonocea session. 

These early findings support further evaluation of Sonocea within performance environments.

Feasibility data only. The pilot was uncontrolled and does not establish causation or improvement in sporting performance.

Real-world deployment

From research to scalable professional use

Sonocea technology powers the Rest & Restore Protocol™, licensed to Unyte Health as part of its suite of listening-based solutions for clinicians and therapists.

The Rest & Restore Protocol is designed to support restoration and recovery, giving professionals a simple, non-invasive way to incorporate nervous system regulation into their work with clients.

Digitally Delivered

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

Digitally Delivered

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

Subscription-based

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

Digitally Delivered

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

Built to scale

A single professional subscription can support multiple clients, with additional client access added as required.

Built to scale

A single professional subscription can support multiple clients, with additional client access added as required.

Subscription-based

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

Built to scale

A single professional subscription can support multiple clients, with additional client access added as required.

Subscription-based

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

Subscription-based

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

Subscription-based

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

Subscription-based

The Rest & Restore Protocol is available through an annual subscription model, enabling professionals to use the protocol across multiple clients.

The Unyte partnership demonstrates how Sonocea technology can be licensed, digitally delivered and scaled through an established professional platform - without specialist hardware or complex infrastructure.

Explore the Rest & Restore Protocol at Unyte Health

The Unyte partnership demonstrates how Sonocea technology can be licensed, digitally delivered and scaled through an established professional platform - without specialist hardware or complex infrastructure.

Explore

The Unyte partnership demonstrates how Sonocea technology can be licensed, digitally delivered and scaled through an established professional platform - without specialist hardware or complex infrastructure.

Explore the Rest & Restore Protocol at Unyte Health

Company

Company

About Sonocea

Built on five decades of autonomic neuroscience

Sonocea brings together Professor Stephen W. Porges’ five decades of research into the autonomic nervous system with Anthony Gorry’s 20+ years developing and commercializing audio technology and immersive experiences.

Together, they co-founded Sonocea and co-invented Sonic Augmentation Technology - bringing together autonomic neuroscience and signal-generation technology in a proprietary acoustic technology platform designed for real-world use.

Professor Stephen W. Porges, PhD

Co-Founder & Chief Science Officer

Internationally recognized neuroscientist whose work has transformed understanding of the autonomic nervous system. 400+ peer-reviewed publications · 70,000+ citations

Read Stephen’s Bio

Professor Stephen W. Porges, PhD

Co-Founder & Chief Science Officer

Read bio

Anthony Gorry

Co-Founder & Chief Executive Officer

Technology entrepreneur with more than 20 years’ experience developing and commercializing audio technology and immersive experiences.

Read Anthony’s Bio

Anthony Gorry

Co-Founder & Chief Executive Officer

Read bio

Leadership

The expertise to turn science into scale

The wider leadership team adds deep experience across operations, medicine, technology and finance - supporting the development, deployment and commercialization of the Sonocea platform.

Co-Founder & Chief Operating Officer

Sarah Underwood

Former COO Asia-Pacific Technology at Credit Suisse First Boston. Sarah has led global change initiatives spanning technology, finance and operations.

Sarah Underwood

Co-Founder and Chief Operating Officer

Chief Medical Advisor

Dr. Peter Staats, MD MBA FIPP ABIPP

Founder of the Division of Pain Medicine at Johns Hopkins and former CMO of National Spine and Pain Centers, with extensive expertise in neuromodulation and interventional pain.

Dr. Peter Staats, MD MBA FIPP ABIPP

Chief Medical Advisor

Technology Advisor

Stefan Traykovski 

Software engineer and technology leader with 17+ years building software and AI platforms. Founder of four ventures, including one successful exit.

Stefan Traykovski 

Technology Advisor

Fractional Chief Financial Officer

Charles Vivian

Technology investor across private equity and public markets, with corporate finance experience as a former solicitor, startup founder, investor and advisor.

Charles Vivian

Fractional Chief Financial Officer

Scientific & medical advisory board

World-class expertise across science & medicine

Extending Sonocea expertise across neuroscience, medicine and areas of future clinical research.

MD MBA FIPP ABIPP

C. Sue Carter, PhD

Former COO Asia-Pacific Technology at Credit Suisse First Boston. Sarah has led global change initiatives spanning technology, finance and operations.

C. Sue Carter, PhD

Women’s Health & Social Biology Advisor

Read bio

MD MBA FIPP ABIPP

Robert K. Naviaux, MD PhD

Former COO Asia-Pacific Technology at Credit Suisse First Boston. Sarah has led global change initiatives spanning technology, finance and operations.

Robert K. Naviaux, MD PhD

Metabolic & Complex Chronic Conditions Advisor

Read bio

MD MBA FIPP ABIPP

Robert Dantzer, DVM PhD

Former COO Asia-Pacific Technology at Credit Suisse First Boston. Sarah has led global change initiatives spanning technology, finance and operations.

Robert Dantzer, DVM PhD

Oncology Supportive Care & Fatigue Advisor

Read bio

MD MBA FIPP ABIPP

Dr. Julie R. Korenberg, PhD

Former COO Asia-Pacific Technology at Credit Suisse First Boston. Sarah has led global change initiatives spanning technology, finance and operations.

Dr. Julie R. Korenberg, PhD

Neurodevelopment & Genetics Advisor

Read bio

MD MBA FIPP ABIPP

Dr David M Steinhorn, MD

Former COO Asia-Pacific Technology at Credit Suisse First Boston. Sarah has led global change initiatives spanning technology, finance and operations.

Dr David M Steinhorn, MD

Palliative & Integrative Care Advisor

Read bio

Contact

Us

Contact

Us

Frequently Asked Questions

1. What exactly is Sonocea?

2. How is acoustic neuromodulation different from meditation, music, binaural beats or wellness audio?

3. How does Sonocea acoustic neuromodulation work?

4. What scientific evidence supports Sonocea acoustic neuromodulation?

5. Is Sonocea a medical device?

6. Is Sonocea safe?

7. How is Sonocea delivered?

8. Where can I get Sonocea?

9. Can healthcare professionals use Sonocea with their clients?

10. Where is Sonocea already being used?

11. How can an organization work with Sonocea?

12. Does Sonocea replace therapy or medical treatment?

13. How do you pronounce Sonocea?

Work with Sonocea

Evaluate Sonocea in your organization

Evaluate Sonocea in your organization

Explore how acoustic neuromodulation could support regulation, recovery and readiness for people working and performing under sustained pressure.

Sonocea works with organizations, professional teams, research institutions and commercial partners to evaluate and integrate the technology in real-world environments.

Talk to us

Interested in research?

Sonocea collaborates with academic and clinical researchers to expand the evidence base for acoustic neuromodulation.

Contact

Stay informed

Receive occasional updates on Sonocea research, partnerships and developments.

Investors

Connect with our team to learn more about Sonocea’s technology, commercial strategy and investment opportunities.

Contact

Investors

Connect with our team to learn more about Sonocea’s technology, commercial strategy and investment opportunities.

Contact

Privacy

Terms

Medical Disclaimer

© 2026 Sonocea Inc. All rights reserved.
Sonocea® is a registered trademark of Sonocea Group Limited.
Sonic Augmentation Technology™ and Sonostasis® are trademarks of Sonocea Group Limited.

© 2026 Sonocea Inc. All rights reserved.
Sonocea® is a registered trademark of Sonocea Group Limited.
Sonic Augmentation Technology™ and Sonostasis® are trademarks of Sonocea Group Limited.

Technology

Science & Evidence

Applications

Company

Contact

Privacy

Terms

©2025 Sonocea® Inc